Expanding volumes of data point to mechanisms beyond weight loss and blood sugar control that contribute to cardiovascular ...

In the late 1960s, researchers at the Weizmann Institute of Science, including Professors Michael Sela and Ruth Arnon and Dr.

The U.S. Food and Drug Administration (FDA) has approved a groundbreaking drug, acoramidis (marketed as Attruby), developed ...

A blood-thinning drug which could prevent one in five heart attacks, strokes or heart disease deaths among Britons is being hailed as a major breakthrough by doctors. Results from a landmark study ...

Ozempic, Wegovy and Mounjaro, all GLP-1 anti-obesity medications, may offer health benefits beyond weight loss. Studies show ...

Metoprolol, acebutolol, and propranolol are heart medications linked to weight gain. Other heart medications may cause weight gain, but some might cause weight loss or be weight neutral.

Weight loss drugs like semaglutide may shrink heart muscle as well as waistlines, according to a study from the University of Alberta. The research, published in JACC: Basic to Translational Science, ...